Text Size: A+ A- A • Text Only

Workers' Compensation Division (WCD)

Medical quality initiative -
what we've accomplished / past projects

*MQI - Pharmacy Project*
The WCD Executive Team chartered the MQI Pharmacy Project in July 2006. The project team worked closely with key stakeholders, surveyed workers' compensation (WC) payers, researched pharmacy literature, completed data analyses, and prepared recommendations relating to pharmaceutical cost controls to the WCD Executive Team in January 2007. The Executive Summary and related attachments are found in the links below:
Executive Summary Project charter Definitions and glossary Data Analyses Drug Effectiveness Review Project (DERP) Follow the Pill - U.S. Commercial Pharmaceutical Supply Chain Health Strategy - Payer Prescription Drug Management Survey Heinz Report - The Oregon Blueprint Kaiser Foundation Drug Trends Oregon Payer Survey NCCI Prescription Drug Study- 2004 NCCI Prescription Drug Study- 2006 Update Pharmacy Fee Advisory Task Force 2003 WCRI 2006 Pharmaceuticals Guide for Policymakers


*Treatment and Guidelines Committee*
The Treatment and Guidelines Committee explored the development or adoption of treatment guidelines, development of a training and voluntary certification program for medical providers, and reduction and simplification of paperwork for medical providers. After receiving input from stakeholders throughout the state, the Committee presented its final report to the WCD Executive Committee in March 2006. The report stated that there was minimal interest in adopting treatment guidelines and certifying medical providers. Although many stakeholders were concerned about "outliers", there was no consensus on how to address "outliers". Stakeholders, however, did support the concept of training medical providers and their staff in the principles of workers' compensation, return-to-work, and technical areas of reporting and billing. Treatment & Guidelines Full Report Treatment & Guidelines Stakeholder Meeting Notes


*MQI - Reporting Evaluation Phase (REP)*
The MQI-REP Committee reviewed statute and rule requirements, assessed WCD and the Department of Consumer and Business Services (DCBS) needs for and uses of data obtained, and interviewed providers and industry representatives. In addition, the Committee reviewed and analyzed significant background factors, including recommendations from the Paperwork Reduction Taskforce, the impact of the major contributing cause standard, and the development of electronic data interchange. The Committee presented its final report to the WCD Executive Committee in June 2006. MQI-REP Full Report

Based on the recommendations from the MQI Committees, the Executive Team approved the following projects:
		MQI - Pharmacy
		MQI - EDI (Electronic Data Interchange)
		MQI - Provider Outreach